AEP
54
6
DFS
64
2
PSA
56
3
FMC
23
-3
XYL
35
-2
EXPD
43
-4
KIM
72
2
SRE
63
2
MUR
44
-3
BSX
64
-3
R
70
-3
HRL
35
-3
HRB
59
2
ETN
75
-3
FITB
60
-5
WDC
37
-3
APH
65
-3
V
64
-2
RIG
43
-7
AME
74
-4
AEP
54
6
DFS
64
2
PSA
56
3
FMC
23
-3
XYL
35
-2
EXPD
43
-4
KIM
72
2
SRE
63
2
MUR
44
-3
BSX
64
-3
R
70
-3
HRL
35
-3
HRB
59
2
ETN
75
-3
FITB
60
-5
WDC
37
-3
APH
65
-3
V
64
-2
RIG
43
-7
AME
74
-4
Financhill
Back

Reaves Utility Income Fund Vs. Avidity Biosciences Industry Stock Comparison

Buy
66

UTG
Reaves Utility Income Fund

Last Price:
33.36
Seasonality Move:
2.73%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Buy
66
Reaves Utility Income Fund (UTG) is a Buy

Is Reaves Utility Income Fund a Buy, Sell or Hold?

  • The current Reaves Utility Income Fund [UTG] share price is $33.40. The Score for UTG is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • UTG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UTG Stock Price Chart

What is Reaves Utility Income Fund's stock price today?

  • The Reaves Utility Income Fund share price today is $33.40
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTG is experiencing buying pressure, which is a positive indicator for future bullish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

UTG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.35 Buy
Relative Strength Index (14 RSI): 60.96 Buy
Chaikin Money Flow: 145542 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.26 - 33.26) Buy
Bollinger Bands (100): (28.49 - 32.49) Buy

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

UTG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.21 Buy
20-day SMA: 32.78 Buy
50-day SMA: 32.3 Buy
200-day SMA: 28.66 Buy
8-day EMA: 33.21 Buy
20-day EMA: 32.85 Buy
50-day EMA: 32.09 Buy
200-day EMA: 29.53 Buy

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

Reaves Utility Income Fund Earnings Growth & UTG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.

Reaves Utility Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):